Page 5 - Medication Guide News Today

The FDA is requiring new safety information be included in the labeling for all BCMA- or CD19-directed autologous CAR T-cell immunotherapies.

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced the...

EMERALD-1 is first global Phase III trial to show improved clinical outcome for systemic therapy in combination with TACE in this setting ...

In patients with advanced chronic kidney disease, treatment with Prolia (denosumab) increases the risk of severe hypocalcemia, according to an updated FDA safety alert.

Acorda Therapeutics, Inc. today announced it will regain global commercialization rights to FAMPYRA® following a decision by Biogen to terminate the license and collaboration agreement between the...

(BPT) - This content is provided by MorphoSys and Incyte.

Preliminary total 4Q and full year 2023 net product revenue of $71 million and $204 million, respectively Auvelity preliminary 4Q and full year 2023 net product sales of $49 million and $130 million,...

ZILBRYSQ® is now commercially available by prescription in the United States and dispensed by UCBs selected exclusive specialty pharmacy PANTHERx® Rare Pharmacy.ZILBRYSQ is FDA-approved as the...

CARY, N.C., Dec. 20, 2023 - Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Novartis as a specialty pharmacy...

– If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure – – Interim analysis results from first-of-its-kind Phase III...